Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_provenance.
- NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_provenance.
- NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_assertion evidence source_evidence_literature NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_provenance.
- NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_assertion SIO_000772 18523305 NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_provenance.
- NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_assertion wasDerivedFrom befree-20150227 NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_provenance.
- NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_assertion wasGeneratedBy ECO_0000203 NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_provenance.